## Abstract Peripheral blood monocytes and macrophages from ascitic or solid tumors were obtained from 50 patients with advanced (Stage III or IV) ovarian carcinoma. Blood monocytes and peritoneal macrophages from 76 patients undergoing surgery for benign gynecological diseases were used as control
Augmentation of tumoricidal activity of human monocytes and macrophages by lymphokines
✍ Scribed by Alberto Mantovani; Jack H. Dean; Thomas R. Jerrells; Ronald B. Herberman
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- French
- Weight
- 902 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Monocytes were separated from peripheral blood mononuclear cells of normal human donors by adherence on plastic conditioned by cell lines (microexudatecoated plastic) and harvested by exposure to ethylene diamine tetra‐acetic acid. Cytolytic activity was tested by incubating effector cells for 48 h with the murine SV40‐transformed TU5 kidney line or the human lung cancer‐derived CaLu line prelabelled with tritiated thymidine. Lymphokine‐containing supernatants were obtained from in vitro cultures of lymphoid cells with phytohemagglutinin (PHA)^1^, purified protein derivative (PPD), or with Corynebacterium parvum strains CN6134 or CN5888. The monocytes had significant levels of spontaneous cytotoxicity and exposure to lymphokine supernatants markedly enhanced their tumoricidal activity. Augmentation of monocyte‐mediated cytotoxicity required a minimal exposure to lymphokine supernatants for 4 h and was maximal after 24 h of preincubation. Treatment of the effector cells with anti‐human T‐cell serum and complement did not affect either their spontaneous or their lymphokine‐stimulated cytotoxicity, whereas silica impaired both reactivities. Supernatants of cultures with PHA, PPD and C. parvum CN6134 had significant levels of interferon (IF). Since partially purified human fibroblast or leukocyte IF was able to stimulate monocyte‐mediated cytotoxicity, the IF in these supernatants could play some role in the stimulation of the monocytes. However, C. parvum CN5888 supernatants, which had little IF, enhanced monocyte cytotoxicity as effectively as the C. parvum CN6134 supernatants, strongly suggesting that lymphocyte mediators other than IF can augment the tumoricidal activity of these effector cells. Mature macrophages obtained by in vitro cultivation of monocytes for 4–7 days retained natural cytolytic activity and showed enhanced cytotoxicity in the presence of lymphokines. However, more prolonged in vitro cultivation (> 10 days) resulted in cultures of epithelioid and multinucleated cells which had little natural cytotoxicity and were not responsive to lymphokines.
📜 SIMILAR VOLUMES
In the present study, the ability of lymphokines (MAF and IFNy) and microbial agents (CP and LM) to induce and maintain tumoricidal activity in BMMP in vitro and to enhance local resistance to the DA rat D-I2 ascites tumor in vivo was assessed comparatively. Under standard conditions in vitro, i.e.,
## Abstract Thioglycollate‐stimulated macrophages are known to release a plasminogen activator (PA) into the medium. In this study it was investigated whether macrophages could be activated to release PA after exposure to lymphokines. Macrophage monolayers obtained by 24 h culture of proteose pepto
## Abstract Lymphokines produced by antigenic or mitogenic stimulation of human, guinea pig and mouse lymphocytes were tested for their effects on monocytes or macrophages of the same and heterologous species, to determine whether there is any species restriction in their reactivity. Supernatants f
Human blood rnonocytes in culture differentiate to macrophagelike cells within 1 week. Coinciding with this morphological transition the cells started releasing increasing amounts of the serine proteinase plasminogen activator (PA; Mr 56,000) of the urokinase (u-PA) type and the proteinase inhibitor